Article
IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas.
International journal of cancer - 1 Dec 2009
Hoyo Cathrine, Schildkraut Joellen M, Murphy Susan K, Chow Wong-Ho, Vaughan Thomas L, Risch Harvey, Marks Jeffrey R, Jirtle Randy L, Calingaert Brian, Calingeart Brian, Mayne Susan, Fraumeni Joseph, Gammon Marilie D
Abstract excerpt
The mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) encodes a protein that plays a critical role in tumor suppression, in part by modulating bioavailability of a potent mitogen, insulin-like growth factor-2 (IGF2). We tested the hypothesis that the common nonsynonymous genetic variants in M6P/IGF2R c.901C > G (Leu > Val) in exon 6 and c.5002G > A (Gly > Arg) in exon 34 are associated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
